SynthesisAnnals of the rheumatic diseases2024

Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease.

Sara Bindoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.